News

Public · Published

International Flavors & Fragrances as rising costs cloud outlook

International Flavors & Fragrances reported third-quarter adjusted earnings of $0.83 per share and revenue of $1.94 billion, both slightly above analyst expectations. Revenue rose 3.9% year over year, but operating profit fell 16%. The company warned that fourth-quarter profitability would soften, particularly in Health & Biosciences, as it reinvests amid rising costs.

Published:

Updated:

What happened

International Flavors & Fragrances reported third-quarter adjusted earnings of $0.83 per share and revenue of $1.94 billion, both slightly above analyst expectations. Revenue rose 3.9% year over year, but operating profit fell 16%. The company warned that fourth-quarter profitability would soften, particularly in Health & Biosciences, as it reinvests amid rising costs.

Confirmed

Global impact / market context

Higher sales are not translating into stronger operating profit, suggesting rising costs and reinvestment are absorbing some revenue gains. If that pressure continues, weaker profit growth could limit the benefit of resilient demand for fragrances and food ingredients and challenge expectations built during the stock’s rise this year.

Analyst inference

Shares fell 3.2% in extended trading despite the earnings and revenue beats. The article says the stock had risen about 37% this year, far ahead of the S&P 500’s 11% gain; that rally may have raised expectations for stronger results and a larger outlook increase.

Analyst inference

What to watch

  1. Watch whether fourth-quarter profitability weakens as expected, especially in Health & Biosciences, where IFF says reinvestment in the business will weigh on results. Confirmed
  2. Look for updates on rising costs and reinvestment spending, which could show whether they continue to constrain operating profit even if demand remains resilient. Analyst inference
  3. Track whether revenue growth begins to support operating profit again; the latest quarter had 3.9% higher revenue but a 16% year-over-year decline in operating profit. Analyst inference

Evidence